NCT06152341 is a NA clinical trial of ATC System in Pulmonary Embolism Acute, sponsored by Akura Medical.

Who is sponsoring NCT06152341?

NCT06152341 is sponsored by Akura Medical.

What drugs are being tested in NCT06152341?

Interventions in NCT06152341: ATC System.

What condition does NCT06152341 study?

NCT06152341 studies Pulmonary Embolism Acute.

Is NCT06152341 still recruiting?

NCT06152341 is currently recruiting now. Last updated 28 July 2025.

Last reviewed 2025-07-28 · How we verify

NCT06152341

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Effectiveness of the ATC System in the Treatment of Acute PE

Recruiting now NA Last updated 28 July 2025

What this trial tests

NA trial testing ATC System in Pulmonary Embolism Acute in 30 participants. Currently enrolling.

Timeline

15 May 2024

Primary endpoint
15 August 2025

15 September 2025

Quick facts

Lead sponsor	Akura Medical
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	15 May 2024
Primary completion	15 August 2025
Estimated completion	15 September 2025
Sites	4 locations across Dominican Republic, Brazil

Drugs / interventions tested

ATC System

Conditions studied

Pulmonary Embolism Acute — all drugs for Pulmonary Embolism Acute →

Sponsor

Akura Medical

Who can join

Adults 18 to 90, any sex, with Pulmonary Embolism Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of the ATC System in subjects with acute pulmonary embolism (PE).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Research progress in interventional therapy for acute intermediate-high-risk and high-risk pulmonary embolism.
Wang L, Yu C, Hu K, Guo Y, et al · · 2024 · cited 3× · PMID 39678886 · DOI 10.21037/jtd-24-1049

Verify or expand the search:

Other recruiting trials for Pulmonary Embolism Acute

Currently open trials in the same condition.

NCT07491094 — Repeated Examinations for Typing Pulmonary Embolism · recruiting
NCT07436702 — Optimal Time for Reperfusion in Acute Pulmonary Embolism · recruiting
NCT07029841 — Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong · recruiting
NCT06348459 — Registry of Catheter Intervention in Pulmonary Embolism · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06152341 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Akura Medical
Last refreshed: 28 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06152341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing